Sanofi (TSX:SNY)
Canada flag Canada · Delayed Price · Currency is CAD
22.36
0.00 (0.00%)
Nov 12, 2026, 3:57 PM EST

Sanofi Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
50,98246,71644,28641,10940,30439,175
Revenue Growth
11.00%5.49%7.73%2.00%2.88%4.83%
Gross Profit
37,87233,79331,09128,49028,43526,924
Operating Income
11,3579,6508,8698,12110,3818,565
Net Income
4,1787,8135,5605,4008,3716,223
Earnings Per Share
3.466.374.444.316.674.95
EPS Growth
-53.23%43.55%2.94%-35.31%34.73%-49.28%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dupixent
19,25715,71413,07210,7158,2935,249
Pharma
40,18635,69032,783---
Total Vaccine
7,6677,9368,2987,4747,2296,323
Revenue (Total)
50,98246,71644,28641,61840,56139,175

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,9667,6747,5568,82212,88210,109
Total Debt
19,84520,41017,91318,42321,21222,415
Net Cash (Debt)
-13,879-12,736-10,357-9,601-8,330-12,306
Net Cash Growth
------
Net Cash Per Share
-11.48-10.39-8.25-7.64-6.63-9.78

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,95910,7509,08110,25810,52610,522
Capital Expenditures
-1,986-1,762-1,733-1,619-1,529-1,478
Free Cash Flow
9,9738,9887,3488,6398,9979,044
Free Cash Flow Growth
6.29%22.32%-14.94%-3.98%-0.52%46.72%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.28%72.34%70.20%69.30%70.55%68.73%
Operating Margin
22.28%20.66%20.03%19.75%25.76%21.86%
Pretax Margin
11.59%12.89%15.26%14.88%24.79%20.01%
Profit Margin
8.20%16.72%12.55%13.14%20.77%15.88%
FCF Margin
19.56%19.24%16.59%21.02%22.32%23.09%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8024.1203.9203.7603.5603.330
Dividend Per Share Growth
0%5.10%4.25%5.62%6.91%4.06%
Dividend Yield
3.59%4.94%4.20%4.18%3.96%3.75%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.3412.8821.0420.8413.4617.87
P/FCF Ratio
10.2711.2015.9213.0312.5212.30
PS Ratio
2.012.152.642.742.802.84